Harness Dickey
  • People
  • Global IP Services
    • Practice Areas
    • Industries
    • Case Studies
  • Blog
  • News & Awards
  • About Us
    • Careers
    • Offices
  • IP Atlas
  • Contact Us
  • Client Login

Blog

Subscribe to our Blogs

  • Subscribe to our Blogs

Our business model is to cultivate lawyers who know all there is to know about intellectual property, whether it be special requirements under the America Invents Act (AIA), patenting chemical compositions and pharmaceuticals, current developments in software patenting, or combating “bad patents” in federal court litigation.  Lawyers from our various practice groups enjoy sharing their views in our blogs. Please join our audience and help us enrich the discussion. We welcome your participation and insight.

  • FDA Guidance & Updates

      ALL CATEGORIES

      • Biologics & Biosimilars
        • Antitrust Issues
        • Competitor Dynamics
        • FDA Guidance & Updates
        • Interchangeability
      • BioPharma
      • Chemistry & Nanotechnology
      • Featured
      • Harnessing the Lessons of IP
      • IP Management
      • IPR-PGR
      • Licensing
      • Litigation
      • Patent Prosecution
      • Trademarks
      • Uncategorized
  • All Years
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
  • Authors
    • John H. Ambrose, Jr.John H. Ambrose, Jr. 2
    • Tyson B. BensonTyson B. Benson 2
    • Jewell N. BriggsJewell N. Briggs 6
    • Elizabeth K. BrockElizabeth K. Brock 7
    • Christopher M. CaubleChristopher M. Cauble 1
    • Matthew L. CutlerMatthew L. Cutler 15
    • Donald J. DaleyDonald J. Daley 1
    • Darin W. DeaverDarin W. Deaver 1
    • Nicholas S. DrysdaleNicholas S. Drysdale 6
    • Monte L. FalcoffMonte L. Falcoff 1
    • Glenn E. ForbisGlenn E. Forbis 11
    • Mark A. Frentrup, Ph.D.Mark A. Frentrup, Ph.D. 3
    • Michael GambleMichael Gamble 1
    • Jason A. HeistJason A. Heist 1
    • Hemant M. KeskarHemant M. Keskar 4
    • Sung Pil KimSung Pil Kim 1
    • Elisabeth A. KoralElisabeth A. Koral 9
    • Damian H. Kotsis, Ph.D.Damian H. Kotsis, Ph.D. 4
    • Kisuk LeeKisuk Lee 1
    • Robert J. LenihanRobert J. Lenihan 1
    • Chris K. MillerChris K. Miller 1
    • John E. MunroJohn E. Munro 1
    • Michael R. NyeMichael R. Nye 1
    • Joshua A. PartingtonJoshua A. Partington 2
    • Leanne M. RakersLeanne M. Rakers 15
    • Derek RichmondDerek Richmond 1
    • Douglas A. RobinsonDouglas A. Robinson 15
    • Joel R. SamuelsJoel R. Samuels 10
    • Jeffrey L. SnyderJeffrey L. Snyder 1
    • David L. SuterDavid L. Suter 2
    • Michael L. TaylorMichael L. Taylor 1
    • Jennifer R. TurchynJennifer R. Turchyn 4
    • Michael VarcoMichael Varco 3
    • Joseph E. Walsh, Jr.Joseph E. Walsh, Jr. 1
    • Andrew M. WaxmanAndrew M. Waxman 2
    • Bryan K. WheelockBryan K. Wheelock 15
    • Jennifer M. Woodside WojtalaJennifer M. Woodside Wojtala 12
    • Paul E. Zarek, Ph.D.Paul E. Zarek, Ph.D. 3
  • Harness Dickey Trademark Attorneys St. Louis Detroit Dallas Washington, DC

    September 18, 2018

    The Real World is Irrelevant in Judging the Similarity Between DETROIT ATHLETIC CO. and DETROIT ATHLETIC CLUB

    More

  • September 17, 2018

    Do Over — Different Evidence and Different Evidentiary Standard Allow IPR to Reach Different Conclusion of Validity than ITC

    More

  • September 17, 2018

    Expert Testimony Critical to Determining Meaning of Prior Art to a PHOSITA

    More

  • mage of cracked light bulb to denote IP legal dispute

    September 17, 2018

    Clearly Defining A Term Without Providing Any Way to Determine When it has Been “Optimized” as Claimed Dooms Claims Under 112

    More

  • Harness Dickey IP Litigation PTAB Proceedings

    September 17, 2018

    Petitioner Bears the Ultimate Burden of Persuasion With Respect to Real Party in Interest

    More

  • Harness Dickey IP Attorneys

    September 17, 2018

    Blocking Patent Can Explain Long-Felt But Unmet Need, Reducing Importance of Objective Indicia of Nonobviousness

    More

photo of laboratory and scientist creating biosimilar patents

August 9, 2018

FDA Implements Biosimilar Action Plan to Boost Biosimilar Competition

By: Leanne M. Rakers, Principal

Stay current

  • Subscribe to our Blogs
  • Twitter
  • Facebook
  • LinkedIn
    • Sitemap
    • Privacy Statement
    • Legal Notice

  • © 2018 Harness, Dickey & Pierce, P.L.C. All rights reserved.